RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain CancerI don't think one goes through the trouble of a PP to raise the small amount that he did. I'm with option (2).
Perhaps this will be the incentive for RDW to cut a regional licensing deal whereas he may have previously been stuck on controlling everything.
I personally think that the only option that is timely is to use the new BOD member from Boston to find some American connections and cash asap.
Separately, my own hypothesis about big pharma is that they are profoundly incapable of creativity and innovation. They are stuck on immunotherapy type agents like Keytruda and cannot see outside that box at that time. A compound that resembles iron being absorbed into cancer and then activated by lasers is too much of a reach for them.